Wave life sciences announces oral presentation of preclinical data supporting wve-007's mechanism (inhbe) to reduce fat, preserve muscle, and induce healthy weight loss at ada's annual scientific sessions

Presentation to highlight wve-007 (inhbe galnac-sirna) as a potential novel and unique obesity treatment leading to healthy weight loss and supporting preclinical data demonstrating potent and durable reduction in activin e resulting in fat loss with muscle preservation
WVE Ratings Summary
WVE Quant Ranking